Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen Raises $9.6M in Second-Round Financing to Support Launch of Two Genetic Tests

NEW YORK, Nov. 17 (GenomeWeb News) - Genetic-test developer IntegraGen said today that it has completed a second round of financing worth $9.6 million to support the commercialization of its predictive tests.


IntegraGen said it has so far raised a total of $24 million to support test development and commercialization.


The firm said it plans to market a genetic test for autism in 2006, and a type-II diabetes test in 2008, with other tests slated for launch further in the future.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.